Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 111018334

Galantamine Hydrobromide Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111018334 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
500 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
11-101-8334 500 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 11-101-8334 Supplier MilliporeSigma Supelco Supplier No. PHR1623500MG
Only null left
Add to Cart
Add to Cart

Description

Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Galantamine Hydrobromide, a reversible, competitive acetyl cholinesterase inhibitor, is suggested for the remedy of mild to moderate dementia of the Alzheimer′s type. Featured Industries: Pharmaceutical (small molecule)
TRUSTED_SUSTAINABILITY

Specifications

CAS 4-4-1953
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C17H21 NO3 · HBr
MDL Number MFCD26142877
Synonym Galantamine hydrobromide; Galanthamine hydrobromide
Type Certified Reference Material
Quantity 500 mg
Formula Weight 368.27
Grade Certified Reference Material
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.